Cargando…

Differential Bone Marrow Homing Capacity of VLA-4 and CD38 High Expressing Chronic Lymphocytic Leukemia Cells

BACKGROUND: VLA-4 and CD38 predict a poor clinical outcome in chronic lymphocytic leukemia (CLL). We used CLL samples with discordant VLA-4/CD38 risk to address their individual roles in human bone marrow infiltration (BM), CLL cell homing to murine BM, and in supportive CLL cell-stromal cell intera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brachtl, Gabriele, Sahakyan, Karine, Denk, Ursula, Girbl, Tamara, Alinger, Beate, Hofbauer, Sebastian W., Neureiter, Daniel, Hofbauer, Josefina Piñón, Egle, Alexander, Greil, Richard, Hartmann, Tanja Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158106/ https://www.ncbi.nlm.nih.gov/pubmed/21876768 http://dx.doi.org/10.1371/journal.pone.0023758

Ejemplares similares

The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia
por: Brachtl, Gabriele, et al.
Publicado: (2013)

CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21
por: Ganghammer, Sylvia, et al.
Publicado: (2015)

Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia
por: Gassner, Franz Josef, et al.
Publicado: (2010)

CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells
por: Zaborsky, Nadja, et al.
Publicado: (2016)

The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells
por: Hofbauer, Sebastian W., et al.
Publicado: (2015)

CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity
por: Gutjahr, Julia C., et al.
Publicado: (2020)

CD4+ T cells, but not non-classical monocytes, are dispensable for the development of chronic lymphocytic leukemia in the TCL1-tg murine model
por: Kocher, T, et al.
Publicado: (2016)

The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by “on-demand” addition of plerixafor to granulocyte–colony-stimulating factor
por: Girbl, Tamara, et al.
Publicado: (2014)

Can we be SMaRT-er in our approach to cancer therapy?
por: Gruber, Christina, et al.
Publicado: (2015)

VLA-4 Expression and Activation in B Cell Malignancies: Functional and Clinical Aspects
por: Härzschel, Andrea, et al.
Publicado: (2020)

Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?
por: Stintzing, Sebastian, et al.
Publicado: (2011)

Leveraging immune memory against measles virus as an antitumor strategy in a preclinical model of aggressive squamous cell carcinoma
por: Leb-Reichl, Victoria M, et al.
Publicado: (2021)

Requirement for VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture
Publicado: (1992)

Linked in: the extracellular matrix network in tumour dissemination
por: Leb‐Reichl, V., et al.
Publicado: (2020)

Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins
Publicado: (1995)

Cell adhesion and migration are regulated at distinct stages of thymic T cell development: the roles of fibronectin, VLA4, and VLA5
Publicado: (1996)

Profiling trial burden and patients’ attitudes to improve clinical research in epidermolysis bullosa
por: Prodinger, Christine, et al.
Publicado: (2020)

Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis Bullosa
por: Welponer, Tobias, et al.
Publicado: (2021)

Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines
por: Zopf, Steffen, et al.
Publicado: (2012)

Enhanced Migratory Capacity of T Lymphocytes in Severe Chagasic Patients Is Correlated With VLA-4 and TNF-α Expression
por: Berbert, Luiz Ricardo, et al.
Publicado: (2021)

ROSAT/ASCA/VLA studies of solar proxies
por: Güdel, M, et al.
Publicado: (1996)

Blockade of VLA4 sensitizes leukemic and myeloma tumor cells to CD3 redirection in the bone marrow microenvironment
por: Nair-Gupta, Priyanka, et al.
Publicado: (2020)

Contributions of Dickkopf‐1 to Obesity‐Induced Bone Loss and Marrow Adiposity
por: Colditz, Juliane, et al.
Publicado: (2020)

p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells
por: Browne, A J, et al.
Publicado: (2016)

Epigenetic and metabolic regulation of epidermal homeostasis
por: Wagner, Roland N., et al.
Publicado: (2021)

Transcriptome-Guided Drug Repurposing for Aggressive SCCs
por: Zauner, Roland, et al.
Publicado: (2022)

Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis
Publicado: (1991)

CNS accumulation of regulatory B cells is VLA-4-dependent
por: Lehmann-Horn, Klaus, et al.
Publicado: (2016)

Integrin-directed antibody-based immunotherapy: focus on VLA-4
por: Savino, Wilson, et al.
Publicado: (2021)

What is a good doctor?
por: Steiner-Hofbauer, Verena, et al.
Publicado: (2017)

VLA-4-fibronectin interaction is required for the terminal differentiation of human bone marrow cells capable of spontaneous and high rate immunoglobulin secretion
Publicado: (1992)

Influence of Five Potential Anticancer Drugs on Wnt Pathway and Cell Survival in Human Biliary Tract Cancer Cells
por: WACHTER, Julia, et al.
Publicado: (2011)

RNA Trans-Splicing Modulation via Antisense Molecule Interference
por: Liemberger, Bernadette, et al.
Publicado: (2018)

Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer
por: Woess, Katharina, et al.
Publicado: (2022)

Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia
por: Kern, D, et al.
Publicado: (2015)

Regulation of the VLA integrin-ligand interactions through the beta 1 subunit
Publicado: (1992)

The L1 adhesion molecule is a cellular ligand for VLA-5
Publicado: (1995)

The integrin VLA-4 supports tethering and rolling in flow on VCAM-1
Publicado: (1995)

Expression and pathogenesis of VCAM-1 and VLA-4 cytokines in multiple myeloma
por: Hao, Pan, et al.
Publicado: (2020)

CC16 drives VLA-2-dependent SPLUNC1 expression
por: Iannuzo, Natalie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_44qgpj2861ppjqvjgtbiochmsf